Yourgene Health plc

Yourgene Health plc

Yourgene Health plc is a molecular diagnostics company that develops genetic testing kits and laboratory services, primarily serving the UK and international healthcare markets. Its product portfolio includes non-invasive prenatal testing (NIPT) and other genomic assays, often licensed from academic partners or developed in-house. The firm went public on AIM in London, indicating a corporate rather than family-office structure. Strategy centers on commercializing genetic testing technology through direct sales and partnerships, with a focus on prenatal screening and precision medicine applications. The company holds ISO 13485 certification and operates from a Manchester facility. It has also pursued acquisition of complementary diagnostics firms, though specific deal names are thin in public record. No named principals or team size are publicly captured. The company's public filing obligations provide some financial disclosures, but investment posture and AUM remain opaque. The firm appears to operate as a standalone diagnostics business without the multi-family office or fund structure common in Altss's typical coverage. Structural differentiator: As a publicly traded diagnostics firm, Yourgene Health operates under AIM corporate governance rather than a traditional family office mandate. Its revenue model—selling kits and lab services—distinguishes it from investment-centric entities. Succession and leadership details are not publicly documented.